Study reveal single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia
Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...
Yahoo Finance6h
Moleculin Reports Third Quarter 2024 Financial Results and Provides Corporate Update
On track to start dosing in pivotal, adaptive Phase 3 clinical trial (the "MIRACLE" trial) designed for possible accelerated ...
Kura Oncology’s Promising Catalysts and Clinical Progress Justify Buy Rating
Mizuho Securities analyst Salim Syed has maintained their bullish stance on KURA stock, giving a Buy rating today. Salim Syed’s rating ...
kalkinemedia8h
Why Are Institutional Investors Eyeing Hemogenyx’s CAR-T Therapy...
Highlights,Hemogenyx Pharmaceuticals secures funding for phase I trials of its HEMO-CAR-T therapy.,The therapy focuses on ...
Armed robbery in Revesby9h
AML Drug Resistance Mapped at Single-Cell Level
In a recent publication in Nature Communications, researchers from the Tumor Profiler consortium combined single-cell multi-omics and functional profiling for 21 AML patients to reveal resistance ...
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
About Hemogenyx Pharmaceuticals plc Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and ...
TipRanks on MSN11h
Syncona’s Autolus Gains FDA Approval for Leukemia Therapy
Syncona Shs GBP (GB:SYNC) has released an update. Syncona’s portfolio company, Autolus Therapeutics, has received FDA approval for AUCATZYL®, a ...
Iredell Free News17h
Pulling for Chris! Community rallies to help man battling cancer (Photo Gallery)
As word of his diagnosis spread, friends, neighbors, and even strangers wanted to help. A small committee of friends and ...